# FDA Inspection 1009289 - Biomat USA, Inc. - November 16, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f52ff6ca-caa2-4790-896f-71c8cd6dce1a
Source feed: FDA_Inspections

> FDA Inspection 1009289 for Biomat USA, Inc. on November 16, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009289
- Company Name: Biomat USA, Inc.
- Inspection Date: 2016-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1175252 - 2022-07-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8cad4d62-8236-4db2-bb01-f8a74b6feb10)
- [FDA Inspection 1175252 - 2022-07-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/28d6318a-cfeb-4e61-ae42-aed087913192)
- [FDA Inspection 834657 - 2013-05-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/46bf5bee-c55a-4f91-8e10-d86f5022afc2)
- [FDA Inspection 702178 - 2010-12-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7d25abce-1cdb-42c5-9d33-06ad4144eebc)
- [FDA Inspection 630200 - 2009-10-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/67496a90-4430-4e89-ac3e-c079d10abeb0)

Company: https://www.keypedia.com/companies/biomat-usa-inc/2c66429d-8141-4a9b-bcd7-492297a7cbc0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d